Saudi to participate in Bio Japan

Saudi Arabia is participating in Bio Japan – the world’s oldest biotechnology exhibition and business event – for the first time and presented a seminar on Wednesday in conjunction with the Japan Cooperation Center for the Middle East. (ANJ)

• Leading biotech companies, universities and almost every major global pharmaceutical company takes part in Bio Japan
• Saudi Arabia has launched a comprehensive National Biotechnology Strategy and is investing in biotechnology as a part of Saudi Vision 2030

YOKOHAMA: Saudi Arabia is participating in Bio Japan – the world’s oldest biotechnology exhibition and business event – for the first time and presented a seminar on Wednesday in conjunction with the Japan Cooperation Center for the Middle East.
Leading biotech companies, universities and almost every major global pharmaceutical company takes part in Bio Japan, which focuses on biotechnology, regenerative medicine, and the health care industry in general.
Saudi Arabia has launched a comprehensive National Biotechnology Strategy and is investing in biotechnology as a part of Saudi Vision 2030, recognizing its great potential to drive economic diversification and innovation.
The plan is to foster collaboration between government agencies and private enterprises and unlock the full potential of biotechnology research, development, manufacturing, and commercialization. By unifying efforts and establishing a clear road map, Saudi Arabia seeks to position itself as a global leader in biotechnology and capitalize on the sector’s vast benefits for both domestic and international markets.
Representing Saudi Arabia at the event were Bandar bin Abdulmohsen Al-Knawi, Executive Director General for Health Affairs at the Ministry of National Guard; Ammar Al-Taf, the Assistant Deputy of the Ministry of Investment; and Majed Al-Saadi, the General Manager of Investor Outreach in the Ministry of Investments. Saudi Ambassador to Japan, Dr. Ghazi Binzagr also attended the workshop and the meetings.
Mohammed Al-Dahlawi, director Japan Office Ministry of Investment Saudi Arabia is also participating along with Mohammed Alfehaid, Director, Industrial Biotech, Ministry of Investment Saudi Arabia.
Bio Japan 2024, held in Yokohama and running from October 9th to 11th, brings together key players in the industry, experts, and innovators from around the world to showcase pioneering advancements in biotech, pharmaceuticals, medical devices, and health care technology.
According to the organizers, the conference brings together over 20,000 attendees from 35 countries, including leading biotech companies, research institutions, and government representatives.
Key topics of discussion will include innovations in biopharmaceuticals, advancements in stem cell research and gene therapies, sustainability in biotech, and how AI is revolutionizing drug discovery processes.